Attributions for child behavior in parents of children without behavior disorders and children with attention deficit-hyperactivity disorder.

1997 ◽  
Vol 65 (4) ◽  
pp. 636-645 ◽  
Author(s):  
Charlotte Johnston ◽  
Wendy Freeman
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Child Behavior ◽  
Attention Deficit ◽  
Behavior Disorders ◽  
Hyperactivity Disorder

Module 11: Review, Wrap Up, and Planning for the Future

2020 ◽  
pp. 213-220
Author(s):  
Andrea Chronis-Tuscano ◽  
Kelly O’Brien ◽  
Christina M. Danko
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Child Behavior ◽  
Attention Deficit ◽  
Chronic Condition ◽  
Self Care ◽  
Behavioral Skills ◽  
Professional Help ◽  
Hyperactivity Disorder ◽  
Parents And Children ◽  
Ongoing Monitoring

Attention-deficit/hyperactivity disorder is a chronic condition, requiring ongoing use of behavioral skills learned in this program. Without the support of a therapist, it may be difficult for parents to use these skills consistently. The more that these skills become automatic, the more benefits parents and children will experience. A goal of this module is help parents to think about and prepare for how to apply the principles and strategies presented in this program to possible future issues they encounter with their child and personally. It is important to anticipate and catch problems early, so that parents can engage these tools before problems escalate. Another goal is to ensure that parents have, by now, realized the value of self-care so they can create a supportive, consistent environment for their children. Ongoing monitoring of their mood, parenting, and child behavior will help parents to recognize signs that it is time to seek additional professional help.

Pharmacological Treatments for Attention-Deficit/Hyperactivity Disorder and Disruptive Behavior Disorders

2015 ◽  
Author(s):  
Erica Kass ◽  
Jonathan E. Posner ◽  
Laurence L. Greenhill
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Randomized Controlled Trials ◽  
Disruptive Behavior ◽  
Attention Deficit ◽  
Behavior Disorders ◽  
Disruptive Behavior Disorders ◽  
Controlled Trials ◽  
Type I ◽  
Hyperactivity Disorder ◽  
Randomized Controlled

More than 225 placebo-controlled type 1 investigations demonstrate that psychostimulants are highly effective in reducing core symptoms of attention-deficit/hyperactivity disorder (ADHD) in children and adults. In contrast, there are limited type I studies demonstrating that psychopharmacological management with U.S. Food & Drug Administration-approved agents for ADHD (stimulants and nonstimulants), atypical antipsychotics, and mood stabilizers decrease the defiant and aggressive behavior characteristic of disruptive behavior disorders. Stimulant treatment evidence has been supplemented by two large multisite randomized controlled trials. Randomized controlled trials from the past 15 years continue to report several key adverse events associated with stimulants but have not supported rarer and more serious problems. Although psychostimulants have been shown to retain their efficacy for as long as 14 months, their long-term academic and social benefits are not as robust. Nonstimulant agents for which there is more limited evidence of efficacy include atomoxetine, alpha-agonists, modafinil, and bupropion.

Sign in / Sign up

Export Citation Format

Share Document